Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Alessandro Tozzi, Michela Tantucci, Saverio Marchi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
Salvatore Novello, Daniela Mercatelli, Federica Albanese, et al.
Neurobiology of Disease (2021) Vol. 162, pp. 105579-105579
Open Access | Times Cited: 16
LRRK2 along the Golgi and lysosome connection: a jamming situation
Giovanni Piccoli, Mattia Volta
Biochemical Society Transactions (2021) Vol. 49, Iss. 5, pp. 2063-2072
Open Access | Times Cited: 15
Modeling Parkinson’s disease in LRRK2 rodents
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Neuronal Signaling (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 5
Mn-TAT PTD-Ngb attenuates oxidative injury by an enhanced ROS scavenging ability and the regulation of redox signaling pathway
Cui Zhang, Xuehui Hao, Chang Jia-ying, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 13
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons
Chuyu Chen, Meghan Masotti, Nathaniel Shepard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
Fatema Currim, Reeya Tanwar, Josephine M. Brown-Leung, et al.
NeuroToxicology (2024) Vol. 103, pp. 266-287
Closed Access | Times Cited: 1
Characterization of Hemodynamic Alteration in Parkinson's Disease and Effect on Resting-State Connectivity
Da Zhang, Qianyi Fu, Xue Chen, et al.
Neuroscience (2023) Vol. 524, pp. 233-241
Closed Access | Times Cited: 3
D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesia
Ermanno Florio, Marcello Serra, Robert G. Lewis, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105263-105263
Open Access | Times Cited: 5
LRRK2 Gene Variants Associated With a Higher Risk for Alcohol Dependence in Multiethnic Populations
Pablo Rafael Silveira Oliveira, Lorena Oliveira de Matos, Nathalia Matta Araujo, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 6
Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
Yaiza Corral Nieto, Sokhna M. S. Yakhine-Diop, Paula Moreno-Cruz, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 806-806
Open Access | Times Cited: 2
Aberrant somatic calcium channel function in cNurr1 and LRRK2-G2019S mice
Olga Skiteva, Ning Yao, Ioannis Mantas, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and Implications
Michael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, et al.
eNeuro (2019) Vol. 6, Iss. 6, pp. ENEURO.0453-18.2019
Open Access | Times Cited: 5
Parkinson's disease: The prevalence of the LRRK2-G2019S mutation among the population of the South-West of Morocco
Sofiane Ait Wahmane, Abderrahmane Achbani, Nezha El Mansouri, et al.
Gene Reports (2022) Vol. 27, pp. 101547-101547
Closed Access | Times Cited: 3
Cytosolic non-vesicular dopamine accumulation as the predominant mechanism for developing non-DOPA responsive parkinsonism in late-stage Huntington disease
Rafael Vincent M. Manalo
Medical Hypotheses (2019) Vol. 132, pp. 109377-109377
Closed Access | Times Cited: 3
Pathogenic LRRK2 R1441C mutation is associated with striatal alterations
Harry S. Xenias, Chuyu Chen, Shuo Kang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 3
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes
Andrea Mancini, Erik Stoops, Leentje Demeyer, et al.
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 682-688
Open Access | Times Cited: 1
Effect of the Flavonoid Rutin on the Modulation of the Enteric Nervous System in Experimental Model of Parkinson’s Disease.
Lívia Bacelar de Jesus, Annyta Fernandes Frota, Fillipe M. de Araújo, et al.
(2023)
Open Access | Times Cited: 1
Presynaptic Dysfunction in Parkinson’s Disease
Koyel Kar
(2024), pp. 285-298
Closed Access
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2024)
Open Access
Long-term exposure to PFE-360 in the AAV-α-synuclein rat model: findings and implications
Michael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 2
Pathway-specific deregulation of striatal excitatory synapses in LRRK2 mutations
Chuyu Chen, Giulia Soto, Nicholas M. Bannon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Ludovica Iovino, Veronica Giusti, Francesca Pischedda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies
Magdalena Kurnik‐Łucka, Gniewomir Latacz, Adam Bucki, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38566-38576
Open Access
Previous Page - Page 2

Scroll to top